Tay-Sachs Disease [Tay-Sachsova nemoc]

topical
15
Terms

amaurotická familiární idiocie
GM2 gangliosidóza I
GM2 gangliosidóza, typ I
GM2 gangliosidóza, varianta B
idiocie, amaurotická familiární
nedostatek hexosaminidázy A
Tay Sachsova choroba
Tay Sachsův syndrom
Tay-Sachsova choroba
Tayova-Sachsova nemoc

 

Amaurotic Familial Idiocy
B Variant GM2 Gangliosidosis
B Variant GM2-Gangliosidosis
Deficiency Disease Hexosaminidase A
Familial Amaurotic Idiocy
G(M2) Gangliosidosis, Type I
Gangliosidosis G(M2), Type I
Gangliosidosis GM2 , Type 1
Gangliosidosis GM2, B Variant
Gangliosidosis GM2, Type I
GM2 Gangliosidosis, B Variant
GM2 Gangliosidosis, Type 1
GM2 Gangliosidosis, Type I
GM2-Gangliosidosis, Type I
HexA Deficiency
Hexosaminidase A Deficiency
Hexosaminidase A Deficiency Disease
Hexosaminidase alpha-Subunit Deficiency (Variant B)
Sphingolipidosis, Tay-Sachs
Tay-Sachs Disease, B Variant

Persistent link   https://www.medvik.cz/link/D013661
Definition

An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.

Annotation
TAY-SACHS DISEASE, AB VARIANT is also available
k dispozici je i deskriptor TAY-SACHSOVA NEMOC, VARIANTA AB
DUI
D013661 MeSH Browser
CUI
M0021080
Previous indexing
Lipoidosis (1966-1978)
History note
1979; for AMAUROTIC FAMILIAL IDIOCY use LIPOIDOSIS 1985-2006
Public note
1979; see AMAUROTIC FAMILIAL IDIOCY 1963-1978; for AMAUROTIC FAMILIAL IDIOCY see LIPOIDOSIS 1985-2006, see AMAUROTIC FAMILIAL IDIOCY 1963-1978

C Diseases
C10.228.140 Brain Diseases 1 183
C10.228.140.163 Brain Diseases, Metabolic 85
C10.228.140.163.100.435.825 Sphingolipidoses 12
C10.228.140.163.100.435.825.300 Gangliosidoses 11
C10.228.140.163.100.435.825.300.300 Gangliosidoses, GM2 2
C10.228.140.163.100.435.825.300.300.249 Sandhoff Disease 1
C10.228.140.163.100.435.825.300.300.500 Tay-Sachs Disease 15
C10.228.140.163.100.435.825.300.300.750 Tay-Sachs Disease, AB Variant
C16.320.565.189.435.825 Sphingolipidoses 12
C16.320.565.189.435.825.300 Gangliosidoses 11
C16.320.565.189.435.825.300.300 Gangliosidoses, GM2 2
C16.320.565.189.435.825.300.300.249 Sandhoff Disease 1
C16.320.565.189.435.825.300.300.500 Tay-Sachs Disease 15
C16.320.565.189.435.825.300.300.750 Tay-Sachs Disease, AB Variant
C16.320.565.398.641 Lipidoses 35
C16.320.565.398.641.803 Sphingolipidoses 12
C16.320.565.398.641.803.350 Gangliosidoses 11
C16.320.565.398.641.803.350.300 Gangliosidoses, GM2 2
C16.320.565.398.641.803.350.300.700 Sandhoff Disease 1
C16.320.565.398.641.803.350.300.850 Tay-Sachs Disease 15
C16.320.565.398.641.803.350.300.925 Tay-Sachs Disease, AB Variant
C16.320.565.595 Lysosomal Storage Diseases 73
C16.320.565.595.554.825 Sphingolipidoses 12
C16.320.565.595.554.825.300 Gangliosidoses 11
C16.320.565.595.554.825.300.300 Gangliosidoses, GM2 2
C16.320.565.595.554.825.300.300.800 Sandhoff Disease 1
C16.320.565.595.554.825.300.300.840 Tay-Sachs Disease 15
C16.320.565.595.554.825.300.300.920 Tay-Sachs Disease, AB Variant
C18.452 Metabolic Diseases 1 200
C18.452.132.100.435.825 Sphingolipidoses 12
C18.452.132.100.435.825.300 Gangliosidoses 11
C18.452.132.100.435.825.300.300 Gangliosidoses, GM2 2
C18.452.132.100.435.825.300.300.249 Sandhoff Disease 1
C18.452.132.100.435.825.300.300.500 Tay-Sachs Disease 15
C18.452.132.100.435.825.300.300.750 Tay-Sachs Disease, AB Variant
C18.452.584.563.641 Lipidoses 35
C18.452.584.563.641.803 Sphingolipidoses 12
C18.452.584.563.641.803.350 Gangliosidoses 11
C18.452.584.563.641.803.350.300 Gangliosidoses, GM2 2
C18.452.584.563.641.803.350.300.700 Sandhoff Disease 1
C18.452.584.563.641.803.350.300.850 Tay-Sachs Disease 15
C18.452.584.563.641.803.350.300.925 Tay-Sachs Disease, AB Variant
C18.452.648.189.435.825 Sphingolipidoses 12
C18.452.648.189.435.825.300 Gangliosidoses 11
C18.452.648.189.435.825.300.300 Gangliosidoses, GM2 2
C18.452.648.189.435.825.300.300.249 Sandhoff Disease 1
C18.452.648.189.435.825.300.300.500 Tay-Sachs Disease 15
C18.452.648.189.435.825.300.300.750 Tay-Sachs Disease, AB Variant
C18.452.648.398.641 Lipidoses 35
C18.452.648.398.641.803 Sphingolipidoses 12
C18.452.648.398.641.803.350 Gangliosidoses 11
C18.452.648.398.641.803.350.300 Gangliosidoses, GM2 2
C18.452.648.398.641.803.350.300.700 Sandhoff Disease 1
C18.452.648.398.641.803.350.300.850 Tay-Sachs Disease 15
C18.452.648.398.641.803.350.300.925 Tay-Sachs Disease, AB Variant
C18.452.648.595 Lysosomal Storage Diseases 73
C18.452.648.595.554.825 Sphingolipidoses 12
C18.452.648.595.554.825.300 Gangliosidoses 11
C18.452.648.595.554.825.300.300 Gangliosidoses, GM2 2
C18.452.648.595.554.825.300.300.800 Sandhoff Disease 1
C18.452.648.595.554.825.300.300.840 Tay-Sachs Disease 15
C18.452.648.595.554.825.300.300.920 Tay-Sachs Disease, AB Variant

Gm2-Gangliosidosis, Adult Chronic Type Disease MeSH Browser

Gm2-Gangliosidosis, Variant B1 Disease MeSH Browser

Hexosaminidase A Deficiency, Adult Type Disease MeSH Browser

Tay-Sachs Disease, Juvenile Disease MeSH Browser

Tay-Sachs Disease, Pseudo-AB Variant Disease MeSH Browser

Tay-Sachs Disease, Variant B1 Disease MeSH Browser